← Back to Clinical Trials
Recruiting NCT07346989

NCT07346989 Non-invasive Brain Stimulation on Functional Capacity in Prefrail Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07346989
Status Recruiting
Phase —
Sponsor University of Valencia
Condition Prefrail Elderly
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-01-15
Primary Completion 2028-07

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
tDCStDCS placeboVirtual running

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-01-15 with a primary completion date of 2028-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The general objective of this study is to evaluate the effectiveness of non-invasive neuromodulation combined with a therapeutic exercise program on neuroplasticity and, therefore, on variables related to functional capacity and quality of life, in prefrail older adults.

Eligibility Criteria

Inclusion Criteria: * Age between 65 -90 years old * Meet 1-2 frailty criteria, according to Fried's Criteria. * Ability to understand instructions (Mini-Mental State Examination \>23 points). * Signing of the informed consent. Exclusion Criteria: * History of stroke within the past 6 months or hospital admission for any reason within the past 3 months. * Alterations of the central or peripheral nervous system * Alterations of the vestibular system * Concomitant diseases * Have a neurological pathology, cardiovascular musculoskeletal that contraindicates physical activity * Epilepsy or history, medications that lower the seizure threshold * Cardiac pacemaker, endocranial and hearing implants * History of severe headaches * Uncontrolled intracranial or arterial hypertension * Heart and/or respiratory failure * Implanted medication pump * Skin lesions (psoriasis, eczema) * Serious head surgeries * Completing less than 80% of training sessions

Contact & Investigator

Central Contact

Marta Inglés de la Torre, PHD

✉ marta.ingles@uv.es

📞 0034963864003

Frequently Asked Questions

Who can join the NCT07346989 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Prefrail Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07346989 currently recruiting?

Yes, NCT07346989 is actively recruiting participants. Contact the research team at marta.ingles@uv.es for enrollment information.

Where is the NCT07346989 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT07346989 clinical trial?

NCT07346989 is sponsored by University of Valencia. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology